ĀÜĄņĀŅĀ×

Mark Stautberg has more than 35 years of medical device sales & Marketing experience, most notably at Boston Scientific as the Senior Vice President, Sales for the Cardiovascular businesses. As SVP from 1998-2004, he grew sales ten-fold & led the launch of the TAXUS Drug-Eluting Stent to unprecedented adoption, market share, revenue & speed. During Markā€™s entire fourteen-plus years at Scimed/Boston Scientific, he held key roles that led to their position as the leading company in Interventional Cardiology. Prior to Boston Scientific, Mark had roles of increasing responsibility at Baxter International, including Director of Marketing for the Hospital Supply Division. He also served on numerous medical device company Boards, both private & public, where he mentored commercial teams to success. Mark has a BBA in Marketing from the University of Cincinnati.

Xenterā€™s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligenceā„¢ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity, and invasiveness of cardiac procedures.